Your browser doesn't support javascript.
loading
Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial.
Mahableshwarkar, Atul R; Calabrese, Joseph R; Macek, Thomas A; Budur, Kumar; Adefuye, Adedeji; Dong, Xinxin; Hanson, Elizabeth; Sachs, Gary S.
Afiliação
  • Mahableshwarkar AR; Takeda Development Center Americas, Inc., Deerfield, IL, USA. Electronic address: atul.mahableshwarkar@takeda.com.
  • Calabrese JR; Mood Disorders Program, Department of Psychiatry, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Macek TA; Takeda Development Center Americas, Inc., Deerfield, IL, USA.
  • Budur K; AbbVie Inc., North Chicago, IL, USA.
  • Adefuye A; Baxalta (Part of Shire), Chicago, IL, USA.
  • Dong X; Takeda Development Center Americas, Inc., Deerfield, IL, USA.
  • Hanson E; Takeda Development Center Americas, Inc., Deerfield, IL, USA.
  • Sachs GS; Massachusetts General Hospital, Boston, MA, USA.
J Affect Disord ; 221: 275-282, 2017 10 15.
Article em En | MEDLINE | ID: mdl-28662460
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article